Sinovac Biotech Ltd (SVA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

71.86M
Year ended 2025-12-31
0.0%
3-year compound annual growth
113.66M2009-12-31: 42.98M2010-12-31: 53.06M2011-12-31: 54.61M2012-12-31: 54.93M2013-12-31: 55.80M2014-12-31: 56.11M2015-12-31: 56.31M2016-12-31: 56.95M2017-12-31: 57.10M2018-12-31: 64.98M2019-12-31: 109.69M2020-12-31: 113.66M2021-12-31: 71.60M2022-12-31: 71.76M2023-12-31: 71.85M2024-12-31: 71.86M2025-12-31: 71.86M71.86M
2009-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3171.86M0.0%2026-06-05, From 2025-01-01
2024-12-3171.86M0.0%2026-06-05, From 2024-01-01
2023-12-3171.85M+0.1%2026-06-05, From 2023-01-01
2022-12-3171.76M+0.2%2026-04-30, From 2022-01-01
2021-12-3171.60Mn/c2026-04-30, From 2021-01-01
2020-12-31113.66M+3.6%2023-05-01, From 2020-01-01
2019-12-31109.69M+68.8%2022-04-29, From 2019-01-01
2018-12-3164.98M+13.8%2021-04-22, From 2018-01-01
2017-12-3157.10M+0.3%2020-04-30, From 2017-01-01
2016-12-3156.95M+1.1%2019-04-29, From 2016-01-01
2015-12-3156.31M+0.4%2018-05-11, From 2015-01-01
2014-12-3156.11M+0.6%2017-11-22, From 2014-01-01
2013-12-3155.80M+1.6%2016-04-25, From 2013-01-01
2012-12-3154.93M+0.6%2015-04-29, From 2012-01-01
2011-12-3154.61M+2.9%2014-04-16, From 2011-01-01
2010-12-3153.06M+23.5%2013-05-23, From 2010-01-01
2009-12-3142.98Mn/a2012-04-12, From 2009-01-01